Programs
· 1:1 practitioner-led care · All necessary supplies included · MD-designed protocols · Medication shipped discreetly to your door · 1:1 practitioner-led care · All necessary supplies included · MD-designed protocols · Medication shipped discreetly to your door
(386) 999-9999
Schedule
Lab
Disclaimer: This treatment is available by prescription only through a licensed healthcare provider. A comprehensive evaluation, including a cardiovascular health assessment and medical history, is required prior to initiating treatment. PT-141 can affect blood pressure and heart rate; therefore, ongoing monitoring and follow-up are required throughout the program. This treatment is not appropriate for all patients and is subject to provider discretion.
  • Transform With

PT-141 (Bremelanotide) (Nasal Spray)

Investigational intranasal PT-141 delivery designed for rapid absorption and central nervous system signaling support related to sexual desire pathways.

How It Feels

  • A more spontaneous rise in sexual interest within the active window
  • Increased responsiveness to stimulation and emotional cues
  • Heightened sense of anticipation and engagement
  • A flexible, fast-access desire support experience

Four Rules for Success

  • Use only within clinician-guided protocols
  • Administer with appropriate timing (2–4 hours prior)
  • Do not exceed prescribed frequency limits
  • Avoid combining with other CNS-active sprays or stimulants
Book Your Consultation
PROVIDER-SUPPORTED PROGRAMS
MEDICATION SHIPPED DISCREETLY TO YOUR DOOR
1:1 PRACTITIONER-LED CARE
ALL NECESSARY SUPPLIES ALWAYS FREE
BEST MEDICATION PRICES
PROVIDER-SUPPORTED PROGRAMS
MEDICATION SHIPPED DISCREETLY TO YOUR DOOR
1:1 PRACTITIONER-LED CARE
ALL NECESSARY SUPPLIES ALWAYS FREE
BEST MEDICATION PRICES

The Science Behind PT-141

Intranasal delivery supports rapid systemic absorption, allowing melanocortin receptor agonism to influence hypothalamic pathways associated with sexual desire and reward processing.

Usage & Dosage

  • Intranasal spray administration
  • Typically used 2–4 hours before activity
  • Onset may vary based on individual absorption
  • Duration generally spans 24–72 hours
  • Clinician-defined frequency limits apply
Book Your Consultation
Disclaimer: This treatment is available by prescription only through a licensed healthcare provider. A comprehensive evaluation, including a cardiovascular health assessment and medical history, is required prior to initiating treatment. PT-141 can affect blood pressure and heart rate; therefore, ongoing monitoring and follow-up are required throughout the program. This treatment is not appropriate for all patients and is subject to provider discretion.